Last reviewed · How we verify

NCT03780881: EXPECD4

EXperimental Paradigm to Investigate Expectation Change in Depression 4

Completed NA Last updated 5 December 2023
What this trial tests

NA trial testing Expectation confirmation in Major Depressive Disorder in 171 participants. Completed in 31 August 2019.

Timeline
11 November 2018
Primary endpoint
30 March 2019
31 August 2019

Quick facts

Lead sponsorPhilipps University Marburg
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposebasic science
Enrollment171
Start date11 November 2018
Primary completion30 March 2019
Estimated completion31 August 2019
Sites1 location across Germany

Drugs / interventions tested

Conditions studied

Sponsor

Philipps University Marburg

Who can join

18 and older, any sex, with Major Depressive Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Research has shown that people with depressive symptoms maintain negative expectations even if they have positive experiences that contradict their expectations. Healthy people, however, change their expectations after unexpected positive experiences. In this experimental study, it will now be examined whether there are also differences between healthy people and people with depressive symptoms in dealing with unexpected negative experiences.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Major Depressive Disorder

Currently open trials in the same condition.

Other Philipps University Marburg trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03780881.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing